Financial insights of TMDX

MyFinsight

For the quarter ending 2026-03-31, TMDX made $173,933K in revenue. $7,315K in net income. Net profit margin of 4.21%.

Income Statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Total revenue	173,933	160,764	143,823	157,370
Product	24,308	23,402	18,687	19,421
Service	48,464	43,948	40,561	41,360
Total cost of revenue	72,772	67,350	59,248	60,781
Gross profit	101,161	93,414	84,575	96,589
Research, development and clinical trials	24,879	20,701	15,260	15,934
Selling, general and administrative	62,985	51,440	46,015	44,088
Total operating expenses	87,864	72,141	61,275	60,022
Income from operations	13,297	21,273	23,300	36,567
Interest expense	7,170	3,354	3,491	3,476
Interest income and other income (expense), net	2,358	3,714	3,222	3,091
Total other expense, net	-4,812	360	-269	-385
Income before income taxes	8,485	21,633	23,031	36,182
Provision for income taxes	1,170	-83,750	-1,288	1,275
Net income	7,315	105,383	24,319	34,907

Basic EPS	0.21	3.079	0.71	1.03
Diluted EPS	0.2	2.574	0.66	0.92
Basic Average Shares	34,384,207	34,227,148	34,112,452	33,912,669
Diluted Average Shares	36,194,023	40,941,313	40,748,023	40,558,953

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.